Cancer Imaging is the official journal of the International Cancer Imaging Society (ICIS)
Articles
Page 5 of 20
-
Citation: Cancer Imaging 2014 14(Suppl 1):O5
-
Locoregional therapy of renal cancer
Citation: Cancer Imaging 2014 14(Suppl 1):O20 -
Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanoma
In patients with metastatic melanoma and KIT amplifications and/or mutations, therapy with imatinib mesylate may prolong survival. 18F-labeled 2-fluoro-2-deoxy-D-glucose (18F-FDG) PET/CT may be used to assess met...
Citation: Cancer Imaging 2014 14:30 -
Usefulness of DWI in preoperative assessment of deep myometrial invasion in patients with endometrial carcinoma: a systematic review and meta-analysis
The objective of this study was to perform a systematic review and a meta-analysis in order to estimate the diagnostic accuracy of diffusion weighted imaging (DWI) in the preoperative assessment of deep myomet...
Citation: Cancer Imaging 2014 14:32 -
Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab
Dynamic susceptibility contrast (DSC)-MRI is a well-established perfusion MR imaging technique for estimating relative cerebral blood volume (CBV) in primary brain tumors; however, tumors localized to regions ...
Citation: Cancer Imaging 2014 14:31 -
Morphological factors differentiating between early lung adenocarcinomas appearing as pure ground-glass nodules measuring ≤10 mm on thin-section computed tomography
We aimed to compare the morphological features of pure ground-glass nodules (GGNs; diameter, ≤10 mm) on thin-section computed tomography (TSCT) with their histopathological results in order to identify TSCT fe...
Citation: Cancer Imaging 2014 14:33 -
The use of FDG-PET in diffuse large B cell lymphoma (DLBCL): predicting outcome following first line therapy
Positron emission tomography (PET) using 18fluoro-2-deoxyglucose (FDG) has become a standard clinical tool for staging and response assessment in aggressive lymphomas. The use of PET scans in clinical trials is s...
Citation: Cancer Imaging 2014 14:34 -
Added value of advanced over conventional magnetic resonance imaging in grading gliomas and other primary brain tumors
Although conventional MR imaging (MRI) is the most widely used non-invasive technique for brain tumor grading, its accuracy has been reported to be relatively low. Advanced MR techniques, such as perfusion-wei...
Citation: Cancer Imaging 2014 14:35 -
Computer-aided detection (CAD) system for breast MRI in assessment of local tumor extent, nodal status, and multifocality of invasive breast cancers: preliminary study
We aimed to investigate the efficacy of computer-aided detection (CAD) for MRI in the assessment of tumor extent, lymph node status, and multifocality in invasive breast cancers in comparison with other breas...
Citation: Cancer Imaging 2015 15:1 -
FDG-PET/CT for pre-operative staging and prognostic stratification of patients with high-grade prostate cancer at biopsy
The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in prostate cancer (PCa) has not been well defined yet. Because high-grade PCa tends to exhibit increased glycolyti...
Citation: Cancer Imaging 2015 15:2 -
Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies
Magnetic resonance imaging (MRI) has an established role in imaging pelvic gynaecological malignancies. It is routinely used in staging endometrial and cervical cancer, characterizing adnexal masses, selecting...
Citation: Cancer Imaging 2015 15:3 -
Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging
Dynamic contrast-enhanced MRI (DCE-MRI) estimates vascular permeability of brain tumors, and susceptibility-weighted imaging (SWI) may demonstrate tumor vascularity by intratumoral susceptibility signals (ITSS...
Citation: Cancer Imaging 2015 15:4 -
Neuroblastoma and nephroblastoma: a radiological review
Neuroblastoma (NBL) is the most common extra-cranial tumour in childhood. It can present as an abdominal mass, but is usually metastatic at diagnosis so the symptomatology can be varied. Nephroblastoma, also m...
Citation: Cancer Imaging 2015 15:5 -
Diffusion-weighted MR neurography for the assessment of brachial plexopathy in oncological practice
To evaluate diffusion-weighted MR neurography (DW-MRN) for visualizing the brachial plexus and for the assessment of brachial plexopathy.
Citation: Cancer Imaging 2015 15:6 -
Trans-arterial chemoembolization and external beam radiation therapy for treatment of hepatocellular carcinoma with a tumor thrombus in the inferior vena cava and right atrium
Hepatocellular carcinoma (HCC) with a tumor thrombus in the inferior vena cava (IVC) and right atrium (RA) rarely occurs and is usually associated with extremely poor prognosis, we carried out this study to ev...
Citation: Cancer Imaging 2015 15:7 -
Relevance of computerized tomography in the preoperative evaluation of patients with vulvar cancer: a prospective study
The purpose of the study was to determine whether inclusion of computerized tomography (CT) in the prospective evaluation of vulvar cancer changed the surgical treatment strategy in terms of detection of lymph...
Citation: Cancer Imaging 2015 15:8 -
STatistically Assigned Response Criteria in Solid Tumors (STARCIST)
Several reproducibility studies have established good test-retest reliability of FDG-PET in various oncology settings. However, these studies are based on relatively short inter-scan periods of 1–3 days while,...
Citation: Cancer Imaging 2015 15:9 -
Multi-modal imaging of tumor cellularity and Tryptophan metabolism in human Gliomas
To assess gliomas using image-based estimation of cellularity, we utilized isotropic diffusion spectrum imaging (IDSI) on clinically feasible diffusion tensor imaging (DTI) and compared it with amino acid upta...
Citation: Cancer Imaging 2015 15:10 -
Diagnostic value of 18F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA
The diagnostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) as the first imaging approach in the evaluation of rising carcinoembryonic antigen (CEA) is not cle...
Citation: Cancer Imaging 2015 15:11 -
Semi-automated segmentation of pre-operative low grade gliomas in magnetic resonance imaging
Segmentation of pre-operative low-grade gliomas (LGGs) from magnetic resonance imaging is a crucial step for studying imaging biomarkers. However, segmentation of LGGs is particularly challenging because they ...
Citation: Cancer Imaging 2015 15:12 -
Primary hepatic neuroendocrine tumors: comparing CT and MRI features with pathology
Primary hepatic neuroendocrine tumors (PHNET) are extremely rare and difficult to distinguish from primary and metastatic liver cancers since PHNETs blood supply comes from the liver artery. This study aims to...
Citation: Cancer Imaging 2015 15:13 -
The presurgical T staging of non-small cell lung cancer: efficacy comparison of 64-MDCT and 3.0 T MRI
Lung cancer has been the main concern of the cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) is reported the most common subtype of lung cancer. Initial staging of NSCLC is highly associate...
Citation: Cancer Imaging 2015 15:14 -
FDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinoma
Metastatic renal cell carcinoma has a poor prognosis and an intrinsic resistance to standard treatment. Sunitinib is an oral receptor tyrosine kinase inhibitor that has been used as a first-line targeted thera...
Citation: Cancer Imaging 2015 15:15 -
Approximation of head and neck cancer volumes in contrast enhanced CT
Tumor volume may serve as a predictor of response to radiochemotherapy (RCT) in head and neck squamous cell carcinoma (HNSCC). Computer assisted tumor volumetry requires time-consuming slice-by-slice manual or...
Citation: Cancer Imaging 2015 15:16 -
Multiparametric magnetic resonance tomography and MRI/TRUS-fusion-biopsy for index lesion detection: correlation with radical prostatectomy specimen
Citation: Cancer Imaging 2015 15(Suppl 1):S1 -
Establishing proforma reporting in a busy DGH
Citation: Cancer Imaging 2015 15(Suppl 1):O2 -
Spots and dots in the bones
Citation: Cancer Imaging 2015 15(Suppl 1):O4 -
Imaging of IPMN of the pancreas: evaluation of malignant potential and resectability
Citation: Cancer Imaging 2015 15(Suppl 1):O6 -
Oxygen-enhanced MRI can accurately identify, quantify and map tumour hypoxia in preclinical models
Citation: Cancer Imaging 2015 15(Suppl 1):P9 -
Role of molecular functional imaging in present era of evidence based cancer medicine: to image or to imagine?
Citation: Cancer Imaging 2015 15(Suppl 1):P10 -
Quantification of tumour heterogeneity and glucose metabolism on pre-chemoradiation PET/CT predicts survival in anal cancer
Citation: Cancer Imaging 2015 15(Suppl 1):S11 -
An imaging review of extramedullary myeloma
Citation: Cancer Imaging 2015 15(Suppl 1):P12 -
Radiogenomics of glioblastoma: a window into its imaging and molecular variability
Citation: Cancer Imaging 2015 15(Suppl 1):P14 -
Imaging tumour response - challenges
Citation: Cancer Imaging 2015 15(Suppl 1):O14 -
The value of head imaging after PET-CT staging in NSCLC
Citation: Cancer Imaging 2015 15(Suppl 1):P16 -
Accuracy of MRI for prediction of response to neo-adjuvant chemotherapy in triple negative breast cancer
Citation: Cancer Imaging 2015 15(Suppl 1):P18 -
The role of magnetic resonance imaging (MRI) in invasive lobular breast cancer based on mammographic density
Citation: Cancer Imaging 2015 15(Suppl 1):P20 -
Lung cancer staging
Citation: Cancer Imaging 2015 15(Suppl 1):O20 -
CT characteristic of early local recurrence after resection of the squamous cell carcinoma: comparison with CT characteristics of granulation tissue at stump site
Citation: Cancer Imaging 2015 15(Suppl 1):P22 -
Imaging spectrum of lung adenocarcinoma with histopathological correlation
Citation: Cancer Imaging 2015 15(Suppl 1):P24 -
Thoracic pseudotumours: a pictorial essay
Citation: Cancer Imaging 2015 15(Suppl 1):P26 -
Structured reporting of metastatic disease for improving communication in comprehensive cancer centers- a feasibility study
Citation: Cancer Imaging 2015 15(Suppl 1):P30 -
Paediatric renal tumors
Citation: Cancer Imaging 2015 15(Suppl 1):O37 -
The value of 68Ga-PSMA enhanced PET-CT and MR-PET in patients with biochemical recurrent prostate cancer
Citation: Cancer Imaging 2015 15(Suppl 1):P39 -
Role of high resolution MR in assessment of cervical uterine carcinoma: staging, treatment planning and correlation with histopathology findings
Citation: Cancer Imaging 2015 15(Suppl 1):P43 -
Female pelvic malignancy: spectrum encountered in district hospital: an aid to a general radiologist
Citation: Cancer Imaging 2015 15(Suppl 1):P45 -
Value of DWI volumetry for assessment of complete rectal cancer response after CRT
Citation: Cancer Imaging 2015 15(Suppl 1):P47 -
Imaging of pheochromocytoma and paraganglioma: moving beyond “lumpology” with SSTR, FDG and MIBG molecular imaging
Citation: Cancer Imaging 2015 15(Suppl 1):P49 -
Dual-energy CT in oncology: technical principles and clinical prospects
Citation: Cancer Imaging 2015 15(Suppl 1):P51 -
The value of the FDG-GaTate and proliferation marker (ki-67) in the assessment of neuroendocrine tumours (NETs)
Citation: Cancer Imaging 2015 15(Suppl 1):P53
Official journal of
Follow
Annual Journal Metrics
-
2022 Citation Impact
4.9 - 2-year Impact Factor
4.7 - 5-year Impact Factor
1.636 - SNIP (Source Normalized Impact per Paper)
1.231 - SJR (SCImago Journal Rank)2023 Speed
13 days submission to first editorial decision for all manuscripts (Median)
123 days submission to accept (Median)2023 Usage
1,045,188 downloads
349 Altmetric mentions